Xiang ZL - Search Results

1

A sequence polymorphism on 8q24 is associated with survival in hepatocellular carcinoma patients who received radiation therapy.

Zhao XM, Xiang ZL, Chen YX, Yang P, Hu Y, Zeng ZC. Zhao XM, et al. Among authors: xiang zl. Sci Rep. 2018 Feb 2;8(1):2264. doi: 10.1038/s41598-018-20700-x. Sci Rep. 2018. PMID: 29396413 Free PMC article.

2

Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival.

Xiang ZL, Zeng ZC, Tang ZY, Fan J, Zhuang PY, Liang Y, Tan YS, He J. Xiang ZL, et al. BMC Cancer. 2009 Jun 9;9:176. doi: 10.1186/1471-2407-9-176. BMC Cancer. 2009. PMID: 19508713 Free PMC article.

3

Increased expression of vascular endothelial growth factor-C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome.

Xiang Z, Zeng Z, Tang Z, Fan J, Sun H, Wu W, Tan Y. Xiang Z, et al. Cancer J. 2009 Nov-Dec;15(6):519-25. doi: 10.1097/PPO.0b013e3181c6aa6b. Cancer J. 2009. PMID: 20010172

4

[Nuclear accumulation of CXCR4 and overexpressions of VEGF-C and CK19 are associated with a higher risk of lymph node metastasis in hepatocellular carcinoma].

Xiang ZL, Zeng ZC, Tang ZY, Fan J, Sun HC, Wu WZ, Tan YS. Xiang ZL, et al. Zhonghua Zhong Liu Za Zhi. 2010 May;32(5):344-9. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20723431 Chinese.

5

Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma.

Xiang ZL, Zeng ZC, Tang ZY, Fan J, Sun HC, Tan YS. Xiang ZL, et al. Mol Biol Rep. 2011 Jun;38(5):3531-9. doi: 10.1007/s11033-010-0463-x. Epub 2010 Nov 23. Mol Biol Rep. 2011. PMID: 21104440

6

The expression of HIF-1α in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome.

Xiang ZL, Zeng ZC, Fan J, Tang ZY, He J, Zeng HY, Chang JY. Xiang ZL, et al. Mol Biol Rep. 2012 Feb;39(2):2021-9. doi: 10.1007/s11033-011-0949-1. Epub 2011 Jun 7. Mol Biol Rep. 2012. PMID: 21647551

7

Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma.

Xiang ZL, Zeng ZC, Tang ZY, Fan J, He J, Zeng HY, Zhu XD. Xiang ZL, et al. Oncologist. 2011;16(7):1028-39. doi: 10.1634/theoncologist.2010-0358. Epub 2011 Jun 10. Oncologist. 2011. PMID: 21665914 Free PMC article.

8

Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1α, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma.

Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zeng HY, Gao DM. Xiang ZL, et al. Clin Cancer Res. 2011 Aug 15;17(16):5463-72. doi: 10.1158/1078-0432.CCR-10-3096. Epub 2011 Jun 28. Clin Cancer Res. 2011. PMID: 21712445

9

A clinicopathological model to predict bone metastasis in hepatocellular carcinoma.

Xiang ZL, Zeng ZC, Fan J, Wu WZ, He J, Zeng HY, Tang ZY. Xiang ZL, et al. J Cancer Res Clin Oncol. 2011 Dec;137(12):1791-7. doi: 10.1007/s00432-011-1060-7. Epub 2011 Sep 14. J Cancer Res Clin Oncol. 2011. PMID: 21915751

10

Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma.

Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zeng HY. Xiang ZL, et al. Mol Biol Rep. 2012 May;39(5):6001-6. doi: 10.1007/s11033-011-1413-y. Epub 2011 Dec 29. Mol Biol Rep. 2012. PMID: 22205539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters